FGEN: FibroGen, Inc. Company Short-Term Debt

Symbol and logo of brand FibroGen (FGEN)

This short-term liabilities chart demonstrates the resilience of an asset shielded from macroeconomic shocks. The current figure is recorded at 0.00. Business stability relies on the monopoly of the drug Evrenzo in treating anemia. Management efficiency is supported by outsourcing logistics and trials to external contractors, allowing FibroGen, Inc. (FGEN) to focus on deep fibrosis research.

FGEN (FibroGen Inc) Company Short-Term Debts history from 07/04/2022 to 01/08/2026
Mass-produced product of fibrogen.com

Stable capacity utilization at FibroGen, Inc. (FGEN) enables effective management of credit obligations under one year, reflecting the total volume of loans maturing in less than twelve months. This indicator measures the issuer's current solvency by assessing the company's ability to service short-term debt without compromising operational activities, confirming high liquidity and the quality of the business assets.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Theravance Corp TBPH|Company Short-Term Debt Aquestive Therapeutics (AQST)|SCPH (scpharmaceuticals.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TECX (Tectonic Therapeutic)|TNXP (Tonix Pharma) - Current Liabilities|SXT China - Company Short-Term Debts|Short-Term Debt Volume Eupraxia Pharmaceuticals EPRX|BHST: Company Short-Term Debts|EXOZ (invizyne.com) - Company Short-Term Debt|Company Short-Term Debt Oramed|ENTX: Company Short-Term Loans and Borrowings|Company Short-Term Debt MindWalk (HYFT)|ABVC - Short-Term Debt|Company Short-Term Debts CPIX (Cumberland Pharmaceuticals)|Short-Term Indebtedness quantumbiopharma.com|Telomir Pharmaceuticals, Inc. - Company Short-Term Debts|Short-Term Debt Rani Therapeutics|synergychc.com (SNYR) - Company Short-Term Debt|Company Short-Term Indebtedness RLYB|Company Current Liabilities LEXX|PULM: Company Short-Term Loans and Borrowings|Company Short-Term Debts PTHL|Short-Term Debt Volume aptorumgroup.com|Company Short-Term Debt Lyra Therapeutics, Inc LYRA|IBO: Company Short-Term Indebtedness|TNF Pharma - Company Short-Term Debts|cbdMD, Inc. (YCBD) - Company Current Liabilities|PRFX (PainReform) - Company Current Liabilities|CYTO - Short-Term Debt Volume|LIPO (Lipella) - Company Short-Term Debts|OptiNose Corp - Current Liabilities|Company Short-Term Debts PIRS|procapsgroup.com (PROC) - Short-Term Indebtedness|Company Short-Term Debts PTPI (Petros Pharmaceuticals, Inc.)|Qilian International Holding Group (QLI) - Short-Term Debt|SLRN - Company Short-Term Debt|TFFP (TFF Pharmaceuticals, Inc) - Company Short-Term Indebtedness